Trial description:
Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer. A randomised phase III trial
Contact name:
Dr Alex Martin
Trial start date:
Wednesday, August 9, 2017
Trial end date:
Tuesday, July 4, 2023
Trial tumour type:
Lung
Show on Radiotherapy:
Yes
